FDA Announces Approval of New Drug to Treat Influenza

Oct 31, 2018 | Kimberly Sharpe-Scott

On October 24, the U.S. Food and Drug Administration (FDA) issued a news release announcing its approval of XOFLUZATM (baloxavir marboxil) for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

The FDA’s Commissioner, Scott Gottlieb, M.D., stated, “This is the first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years. With thousands of people getting the flu every year, and many people becoming seriously ill, having safe and effective treatment alternatives is critical. This novel drug provides an important, additional treatment option.”

For additional information, access the FDA’s News Release: FDA approves new drug to treat influenza. For specific details regarding the approval of XOFLUZATM, access the FDA’s NDA Approval letter.


About Kimberly Sharpe-Scott

More posts by Kimberly Sharpe-Scott

Related Posts

Doctor 563428 640
  • COVID-19
  • Health in All Policies
  • Leadership
  • Workforce Development

Preparing Your Local Health Department for the Future

If the pandemic has taught us one thing, it is the importance of preparedness....

Jan 15, 2021 | Guest Author

Preparing Your Local Health Department for the Future

Covid
  • COVID-19
  • Immunization

Dosing intervals for COVID-19 mRNA Vaccine

On January 6, CDC revised Interim Clinical Considerations for Use of mRNA...

Jan 14, 2021 | Beth Hess

Dosing intervals for COVID-19 mRNA Vaccine

  • Opportunity

APHA 2021 Call for Abstracts is Open

Submit an abstract to present and share research with public health leaders and...

Jan 13, 2021 | Anu Varma

APHA 2021 Call for Abstracts is Open

CRC Sim PLER
  • Webinar
  • Emergency Response

CRC SimPLER: A Practice Workshop

To introduce CRC SimPLER, ASTHO and the National Alliance for Radiation...

Jan 11, 2021 | Beth Hess

CRC SimPLER: A Practice Workshop

Coronavirus COVID 19
  • COVID-19
  • Tools & Resources
  • Epidemiology

COVID-19 Genomic Epidemiology Toolkit

The CDC Office of Advanced Molecular Detection (AMD) recently released the...

Jan 11, 2021 | Beth Hess

COVID-19 Genomic Epidemiology Toolkit

Covid
  • COVID-19
  • Webinar

NACCHO COVID-19 Webinar: Increasing Vaccination Coverage...

NACCHO invites local health department leadership and staff to join the...

Jan 08, 2021 | Beth Hess

NACCHO COVID-19 Webinar: Increasing Vaccination Coverage...

Webinar
  • COVID-19
  • Webinar

NACCHO COVID-19 Webinar: Understanding Diverse...

NACCHO invites local health department leadership and staff to join the...

Jan 08, 2021 | Beth Hess

NACCHO COVID-19 Webinar: Understanding Diverse...

Needleexchange 0
  • HIV, STI, & Viral Hepatitis

Join NACCHO’s SSP Monitoring & Evaluation Advisory Group

The National Association of County and City Health Officials (NACCHO), in...

Jan 07, 2021 | Kat Kelley

Join NACCHO’s SSP Monitoring & Evaluation Advisory Group

Orange County
  • COVID-19
  • Immunization

Orange County, NY, administers 800 COVID-19 Vaccines in...

Orange County, NY received 800 doss of the Moderna COVID-19 vaccine the morning...

Jan 07, 2021 | Beth Hess

Orange County, NY, administers 800 COVID-19 Vaccines in...

Back to Top